CD8A and neoplasm: Depletion of CD8+ T cells via administration of monoclonal anti-CD8α (Clone 2.43) overcame the suppression/acceleration of MC38 tumor growth induced by the knock-down/over-expression of MC38-derived Atp6v0a1 (Fig. 3B, C).